PUBLICATIONS |
Peer-Reviewed Publications
|
Manuscripts (Solomon Lab personnel; ‡ equal contribution)
2024
|
|
Congressional Testimony
|
Patents Granted
Patents Pending
- Kevin Solomon, Kok Zhi Lee, Michael Harris, Yu-Hsuan Lee, Loretta Sue Loesch-Fries. Nanoparticles And Biotemplates With Tunable Length And Methods Of Manufacturing The Same, US Patent 11,820,988, issued 21 Nov 2023.
- Kevin Solomon, Kok Zhi Lee, Ethan Hillman, Yu Hong Wang. Tunable, synthetic transcriptional regulators responsive to environmental triggers, US Patent 11,352,632, issued 7 June 2022.
- Michelle A. O’Malley, Kevin V. Solomon, and Charles H. Haitjema. Proteins from Anaerobic Fungi and Uses Thereof, US Patent 10,717,768, issued Jul 21, 2020.
- Michelle A. O'Malley, Kevin V. Solomon. Bioproduction of Methyl Methacrylate, U.S. Patent 10,676,766, issued Jun 9, 2020.
- Kevin Solomon, Tae Seok Moon, Kristala L Prather. Glucose Valves and other Metabolite Valves, US Patent 8,835,138, issued 16 Sep 2014.
Patents Pending
- Mark Blenner, Kevin Solomon, Lummy Monteiro, Jyoti Singh, Ross Klauer. UD22-32: Optimizing Plastic Degradation by Yellow Mealworms and Their Gut Microbiomes, US Provisional Patent Application 63/336,657, filed April 29, 2022
- Kevin Solomon, Kok Zhi Lee. NgAgo as a DNA-guided gene editing tool in prokaryotes and eukaryotes, US Provisional Patent Application 62/643, 814, filed Mar 2018, patent pending.